Giulio Superti-Furga

Giulio Superti-Furga is Scientific Director and CEO of the Research Center for Molecular Medicine (CeMM) at the Austrian Academy of Sciences and Professor of Medical Systems Biology at the Medical University of Vienna. He co-founded multiple biotech companies and chairs EU-LIFE, an alliance of top European life science institutes.

• Education: PhD in Molecular Biology (University of Zurich, Genentech, IMP Vienna)
• Career: Postdoc at EMBL, Professor at University of Bologna, Scientific Director at Cellzome and Ri.MED Foundation

His research focuses on membrane transporters (SLC superfamily) and their roles in cellular metabolism, drug action, and disease. Key areas include cancer (leukemia, drug resistance), innate immunity (adaptor proteins, programmed cell death), and systems biology approaches to drug discovery.

Recent publications highlight SLC transporter networks in metal toxicity, PROTAC resistance, and mitochondrial NAD regulation. The lab develops chemical biology tools and CRISPR libraries for transporter studies.

• Academy Memberships: Austrian Academy of Sciences, Leopoldina, and three others
• Grants: FWF Clinical Research Program ExTrAct AML, WWTF machine learning project mlDIAMANT

The lab team includes project scientists, postdocs, and technicians working on interdisciplinary projects at the interface of biology, medicine, and computational analysis.